Anti androgen treatment for sex offenders

Victim surveys suggest that sexual offending is common, and survivors experience psychological problems. However, much offending goes undetected because of under-reporting and failure to successfully prosecute offenders. One anti androgen treatment for sex offenders a number of naturally occurring substances transmitting ‘messages for action’ to different parts of the body. Data is the information collected through research.

All were male, aged between 16 and 68 years. Five studies took place in the community and two in a secure hospital. Duration varied between three and 13 months. Data analysis involves examining and processing research data, in order to answer the questions that the project is trying to address. Two studies reported reoffending rates formally.

Clinical trials are research studies involving people who use services, which compare a new or different type of treatment with the best treatment currently available. They test whether the new or different treatment is safe, effective and any better than what already exists. Two studies did not report reoffending rates as they both took place in a secure psychiatric facility from which none were discharged. Three community studies did not formally report reoffending at all, focusing largely on ‘abnormal sexual activity’. Secondary outcomes: Studies reported a variety of secondary outcomes. Results suggested that the frequency of self reported deviant sexual fantasies may be reduced by testosterone-suppressing drugs, but not the deviancy itself.